Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Anxiety: Overview

Anxiety: Overview

Anxiety is a common mental disorder featuring excessive worry, fear, and apprehension, significantly affecting daily life. People with anxiety disorders experience persistent and intense anxiety, interrupting their everyday functioning.
Individuals with anxiety often experience a range of physical and emotional symptoms, including sweating, trembling, tachycardia, and disturbances in sleep patterns. These symptoms vary in intensity and frequency but are generally disruptive and distressing.

Behavior Therapy

Behavior Therapy

Behavior therapy incorporates diverse techniques rooted in classical conditioning principles to address maladaptive behaviors and anxiety disorders. These methods aim to reduce avoidance behaviors, foster adaptive coping mechanisms, and alter associations between stimuli and responses, making them effective in a wide range of therapeutic contexts.
Exposure therapy is a cornerstone of behavioral treatment for anxiety disorders. It involves systematic exposure to feared stimuli, either in real...

Anxiolytic Drugs: Overview

Anxiolytic Drugs: Overview

Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...

Generalized Anxiety Disorder

Generalized Anxiety Disorder

Generalized Anxiety Disorder (GAD) is a chronic condition characterized by excessive and uncontrollable worry that persists for at least six months, significantly interfering with daily functioning. Unlike situational anxiety, which arises in response to specific stressors, GAD often occurs without a clear cause. Individuals may experience disproportionate worry about work, health, or relationships. For instance, a person might continuously fear poor health despite normal medical evaluations or...

Social Anxiety Disorder

Social Anxiety Disorder

Social anxiety disorder, also known as social phobia, is characterized by an intense fear of social situations where one might face humiliation, rejection, embarrassment, or negative evaluation. This disorder leads individuals to avoid activities like casual conversations, public speaking, or seemingly simple tasks such as eating, signing documents, or swimming, in public settings. Its impact extends beyond discomfort, often significantly interfering with daily functioning and quality of life.

Classification of Illness

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Brain Aging in Specific Phobia: An ENIGMA-Anxiety Mega-Analysis.

Human brain mapping·2026

Same author

Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression (EPIsoDE): 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial.

Psychotherapy and psychosomatics·2026

Same author

[High on stage? Substance use and performance anxiety among professional musicians].

Der Nervenarzt·2026

Same author

From Expectation to Learning: A Mediational Model of Exposure Therapy Outcome in Anxiety Disorders.

Psychotherapy and psychosomatics·2026

Same author

Utilization of different types of safety behavior during exposure-based CBT for anxiety disorders and its correlates.

Cognitive behaviour therapy·2026

Same author

Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression: The EPISODE Randomized Clinical Trial.

JAMA psychiatry·2026

Search research articles

Related Experiment Video

Updated: Jun 4, 2025

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

[Long-term courses of anxiety disorders].

Jens Plag^1,2, Selina Heuer³, Antonia Bendau⁴

¹Institute for Mental Health and Behavioral Medicine, Fakultät für Medizin,, HMU Health and Medical University Potsdam, Olympischer Weg 1, 14471, Potsdam, Deutschland. jens.plag@hmu-potsdam.de.

|December 20, 2024

Summary

This review highlights how anxiety disorders change across the lifespan, affecting symptoms, function, and quality of life. Early, evidence-based treatment is crucial for long-term success in managing these conditions.

Keywords:

Age-associated differencess Functional level Structural imaging Symptomatology Therapy

More Related Videos

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

Reducing State Anxiety Using Working Memory Maintenance

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

Related Experiment Videos

Last Updated: Jun 4, 2025

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Social Isolation Model: A Noninvasive Rodent Model of Stress and Anxiety

Published on: November 11, 2022

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

The Unpredictable Chronic Mild Stress Protocol for Inducing Anhedonia in Mice

Published on: October 24, 2018

Reducing State Anxiety Using Working Memory Maintenance

Reducing State Anxiety Using Working Memory Maintenance

Published on: July 19, 2017

Area of Science:

Psychiatry and Neuroscience
Developmental Psychology

Background:

Limited comprehensive overviews exist on the long-term clinical trajectory of anxiety disorders.
Understanding neurobiological correlates, risk factors, and treatment influences on prognosis is essential.

Purpose of the Study:

To synthesize findings on disorder-specific symptoms and associated changes in functional level, quality of life, neurocognition, and brain anatomy across the lifespan.
To examine the impact of patient-related, environmental, and therapeutic factors on the course of anxiety disorders.

Main Methods:

Literature search conducted in PubMed focusing on individual components of anxiety disorders.
Inclusion of meta-analyses, longitudinal studies, and cohort studies.
Presentation of findings stratified by age groups: children/adolescents and early/late adulthood.

Main Results:

Anxiety disorders demonstrate age-associated variations in symptom profiles, functional levels, and quality of life.
Identified risk factors for poor prognosis, particularly in young and middle-aged adults.
Evidence-based psychotherapy and pharmacotherapy show lasting effects post-treatment.

Conclusions:

Age-dependent characteristics and limitations are critical for long-term therapeutic success in anxiety disorders.
Prognostically relevant aspects in diagnostics and treatment must be considered.
Initiating treatment as early as possible is recommended for optimal outcomes.